GSK - 37 Year Stock Price History | GSK

Historical daily share price chart and data for GSK since 1986 adjusted for splits. The latest closing stock price for GSK as of May 30, 2023 is 33.86.
  • The all-time high GSK stock closing price was 55.81 on April 13, 2022.
  • The GSK 52-week high stock price is 55.89, which is 65.1% above the current share price.
  • The GSK 52-week low stock price is 28.46, which is 15.9% below the current share price.
  • The average GSK stock price for the last 52 weeks is 37.06.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
GSK Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2023 35.1067 34.6095 37.9455 33.1726 33.8600 -1.75%
2022 43.2233 51.2663 55.8052 27.8216 34.4624 -33.43%
2021 44.8517 41.8813 52.1702 37.9825 51.7711 26.77%
2020 43.3829 49.5196 50.5434 34.0604 40.8382 -17.65%
2019 42.7959 38.0569 49.9418 38.0067 49.5935 29.19%
2018 38.6566 35.1510 42.0655 33.7803 38.3885 13.71%
2017 37.2655 35.0879 41.1130 32.9903 33.7613 -2.96%
2016 36.4952 34.2571 40.1952 32.9444 34.7898 1.81%
2015 35.7097 33.9973 39.7403 31.3888 34.1724 -0.35%
2014 39.4316 40.2166 43.5681 33.1387 34.2941 -15.68%
2013 37.1763 32.0331 40.6737 31.8880 40.6737 28.90%
2012 31.9890 31.7915 33.9736 30.0398 31.5541 0.67%
2011 27.9808 25.5860 31.4205 23.6825 31.3450 22.60%
2010 24.2642 26.5533 26.9401 20.5481 25.5664 -2.08%
2009 22.0256 21.7089 26.5162 16.2361 26.1083 19.30%
2008 24.7516 28.0319 30.3730 18.8022 21.8850 -22.27%
2007 29.3574 28.9567 32.2397 26.7468 28.1548 -0.83%
2006 28.5334 26.5505 30.9175 26.1285 28.3916 7.95%
2005 25.1155 23.9184 27.8895 22.4687 26.3005 9.87%
2004 21.1117 22.7818 23.9942 19.3920 23.9386 5.55%
2003 19.4316 18.1014 23.0591 15.5898 22.6797 28.80%
2002 19.7479 22.7506 23.2161 15.2006 17.6079 -22.56%
2001 24.2924 25.1064 26.1574 21.9255 22.7369 -9.63%
2000 24.5727 23.8108 27.6715 19.7138 25.1604 5.06%
1999 24.9490 29.4452 31.3628 20.6423 23.9480 -16.98%
1998 24.1316 19.6038 28.8475 19.6038 28.8475 47.92%
1997 16.1186 12.5708 19.5508 12.0699 19.5019 53.28%
1996 11.0952 10.8619 13.6247 9.2019 12.7231 17.14%
1995 8.9744 7.7070 10.8619 7.0165 10.8619 44.39%
1994 6.6966 7.4411 7.8474 5.7171 7.5224 2.30%
1993 6.5098 8.1019 8.1019 5.1117 7.3530 -8.79%
1992 9.1336 10.5824 11.5387 7.5520 8.0612 -23.54%
1991 7.2516 5.3221 10.5426 5.0372 10.5426 98.88%
1990 4.4779 4.0262 5.6054 3.5759 5.3011 30.40%
1989 3.5175 2.9303 4.1232 2.8161 4.0653 38.73%
1988 2.6990 2.7957 3.0627 2.3895 2.9303 8.37%
1987 3.4873 2.2333 4.4258 2.2333 2.7039 21.07%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $70.106B $36.279B
GSK plc is a biopharma company. Its vaccine portfolio protects people from meningitis, shingles, flu, polio, measles and many more. GSK plc, formerly known as GLAXOSMITHKLINE, is based in Brentford, the United Kingdom.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $134.076B 8.19
Bio-Rad Laboratories (BIO.B) United States $11.071B 29.60
QIAGEN (QGEN) Netherlands $10.491B 22.15
Ginkgo Bioworks Holdings (DNA) United States $3.170B 0.00
Arcus Biosciences (RCUS) United States $1.611B 0.00
Biohaven (BHVN) United States $1.059B 0.00
Emergent Biosolutions (EBS) United States $0.412B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.175B 0.00
Enzo Biochem (ENZ) United States $0.114B 0.00
SQZ Biotechnologies (SQZ) United States $0.017B 0.00